openPR Logo
Press release

Revenue Cycle Management Market Forecast to Hit USD 388.21 Billion by 2032, Driven by Rising Healthcare Costs | CAGR of 12.0%

08-21-2025 08:18 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Revenue Cycle Management Market

Revenue Cycle Management Market

The global Revenue Cycle Management Market [https://www.coherentmarketinsights.com/industry-reports/revenue-cycle-management-market] is estimated to be valued at USD 175.50 Bn in 2025 and is expected to reach USD 388.21 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 12.0% from 2025 to 2032. The Revenue Cycle Management (RCM) market is experiencing rapid expansion, driven by the rising need for efficient healthcare billing processes, the transition toward value-based care, and stricter regulatory requirements. Market growth is further fueled by the increasing volume of healthcare claims and the mounting pressure to reduce overall healthcare costs. Additionally, with the accelerating digitization of healthcare operations, the adoption of automated RCM solutions is expected to rise significantly.

Request a Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/6803

Global Revenue Cycle Management Market Key Takeaways

According to Coherent Market Insights (CMI), the global revenue cycle management market size is estimated to reach USD 175.5 Bn in 2025 and further expand at a CAGR of 12% during the assessment period, totaling USD 388.21 Bn by 2032.

Based on type, integrated segment is expected to account for nearly three-fifths of the global revenue cycle management market share in 2025.

By deployment, cloud segment is set to dominate the global industry, accounting for a share of 69.6% by 2025.

In terms of component, software segment is expected to hold a prominent market share of 84.3% in 2025.

As per CMI's new revenue cycle management market analysis, North America is set to maintain its dominance, accounting for over 2/5 of the global market share in 2025.

Asia Pacific revenue cycle management market, spearheaded by China and India, is poised to record fastest growth during the projection period.

Rising Healthcare Costs Spurring Revenue Cycle Management Market Growth

Coherent Market Insights' latest revenue cycle management market report offers insights into key factors driving market growth. One such key growth driver is the increasing healthcare costs.

Healthcare expenditures are steadily rising due to growing geriatric population, increasing incidence of chronic diseases, and high cost associated with advanced medical treatments. These rising costs are prompting healthcare providers to adopt efficient financial management solutions like RCM to optimize billing and collections.

Revenue cycle management solutions help automate and streamline administrative tasks. By doing so, they reduce manual errors, improve efficiency, and control costs. Thus, rising healthcare costs, coupled with increasing patient volume, are expected to boost growth of RCM market during the forecast period.

High Implementation Costs and Data Privacy Concerns Hampering Market Growth

The future revenue cycle management market outlook looks bright. However, ongoing concerns about data privacy and high implementation costs continue to pose a barrier to widespread market expansion.

Setting up advanced revenue cycle management systems can be expensive, especially for small and medium-sized healthcare providers. This cost factor may reduce the overall revenue cycle management market demand in the coming years.

Moreover, revenue cycle management systems handle sensitive patient data, making them prone to data breaches and cyberattacks. These security concerns can also negatively impact growth of the revenue cycle management market during the assessment period.

Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/6803

Healthcare Digitalization Creating Lucrative Growth Opportunities

End users like hospitals, clinics, and diagnostic centers are increasingly adopting digital healthcare solutions to improve operational efficiency and patient outcomes. This shift is driving the demand for automated revenue cycle management (RCM) solutions, which help reduce manual errors and enhance revenue performance. As a result, the rapid digitalization of the healthcare sector is expected to create lucrative growth opportunities for revenue cycle management companies.

Impact of AI on the Revenue Cycle Management Market

Artificial Intelligence (AI) is making a powerful impact on the revenue cycle management (RCM) market. This is due to its ability to drive greater efficiency, accuracy, and cost savings across healthcare systems.

AI-powered tools streamline complex billing processes as well as automate claim submissions and enhance error detection. By doing so, they significantly reduce denials and delays.

Healthcare providers can use machine learning algorithms and predictive analytics to forecast payment trends, optimize coding practices, and improve cash flow management. Thus, AI integration not only accelerates the revenue cycle but also empowers healthcare organizations to focus more on patient care and less on administrative burdens.

Emerging Revenue Cycle Management Market Trends

Evolving healthcare regulations, such as HIPAA in the United States, are expected to uplift demand for advanced RCM systems. These systems assist healthcare providers in ensuring compliance as well as reducing claim denials.

Cloud-based revenue cycle management solutions are gaining immense traction globally. This is due to their benefits like scalability, cost-effectiveness, and accessibility. Growing demand for these cloud-based RCM solutions will likely foster sales growth.

Shift from fee-for-service toward value-based care models is a key growth-shaping trend in the market. This transition introduces complexities in revenue cycles, requiring RCM solutions that can accommodate new reimbursement models as well as analyze patient data for outcomes.

Rising popularity of outsourcing RCM services is expected to play a key role in boosting the overall revenue cycle management market value. Many healthcare providers outsource RCM functions to third-party vendors to cut costs as well as improve efficiency. This is creating high demand for managed RCM services.

Get Customization on this Report: https://www.coherentmarketinsights.com/insight/request-customization/6803

Analyst's View

"The global revenue cycle management industry is set to record robust growth, owing to rising healthcare costs, increasing digitalization of healthcare systems, and growing adoption of cloud-based RCM solutions," said Komal Dighe, a senior analyst at CMI.

Current Events and Their Impact on the Revenue Cycle Management Market

Event

Description and Impact

Surge in AI Regulations Following EU AI Act Implementation

* Description: The EU AI Act, passed recently, introduces strict compliance requirements for healthcare AI tools, including those used in RCM.

* Impact: Revenue cycle management vendors must now ensure transparency and auditability of AI-driven decision-making (e.g., automated denials).

CMS Expansion of Value-Based Care Requirements (Q1 2025)

* Description: CMS mandated updated value-based reporting structures, tying more reimbursement to patient outcomes.

* Impact: Providers are turning to analytics-driven RCM systems that integrate with population health tools to track performance metrics tied to reimbursement, boosting demand for interoperable RCM platforms.

Epic and Google Cloud Partnership

* Description: Major EHR vendor Epic expands collaboration with Google Cloud to improve data interoperability, AI integration, and financial analytics.

* Impact: RCM solutions are being adapted for cloud-native, AI-enhanced infrastructures.

Competitor Insights

Key companies listed in the revenue cycle management market research report:

- Experian Health

- Athenahealth

- Coronis

- Cerner

- Conifer Health Solutions

- GE HealthCare

- Epic Systems

- Optum

- eClinicalWorks

- Change Healthcare

- McKesson Corporation

- Waystar

- R1

- Veradigm LLC

- Experian Health

- Access Healthcare

- AdvantEdge Healthcare Solu

- CareCloud Corporation

Key Developments

In May 2025, Optum introduced Optum Integrity One, its new integrated revenue cycle platform powered by Optum Clinical Language Intelligence. It is designed to reduce administrative burden for healthcare systems.

In May 2025, Smarter Technologies launched the industry's first AI-driven platform for revenue management automation and insights. It is designed to help hospitals and health systems optimize administrative workflows as well as strengthen financial performance.

In May 2025, Infinx Healthcare acquired i3 Verticals' Healthcare Revenue Cycle Management Business to strengthen its market position in the healthcare RCM space.

Market Segmentation

By Type

Standalone

Integrated

By Deployment

Cloud

On Premise

By Component

Software

Service

By Function

Appointment Scheduling

Claims & Denial Management

Medical Coding & Billing

Network Management

Others

By End User

Hospitals

Clinics

Ambulatory Surgical Centres

Diagnostics & Imaging Centres

Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

About Us:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Media Contact
Company Name: Coherent Market Insights
Contact Person: Mr. Raj Shah
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=revenue-cycle-management-market-forecast-to-hit-usd-38821-billion-by-2032-driven-by-rising-healthcare-costs-cagr-of-120]
Phone: 2524771362
Address:533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
City: Burlingame
State: California
Country: United States
Website: https://www.coherentmarketinsights.com/industry-reports/revenue-cycle-management-market [http:// https://www.coherentmarketinsights.com/industry-reports/revenue-cycle-management-market]

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Revenue Cycle Management Market Forecast to Hit USD 388.21 Billion by 2032, Driven by Rising Healthcare Costs | CAGR of 12.0% here

News-ID: 4154881 • Views:

More Releases from ABNewswire

Immuno-Oncology Assays Market to Surpass USD 11.82 Billion by 2032, Driven by Rising Cancer Burden | CAGR of 11.4%
Immuno-Oncology Assays Market to Surpass USD 11.82 Billion by 2032, Driven by Ri …
Global Immuno-Oncology Assays Market [https://www.coherentmarketinsights.com/market-insight/immuno-oncology-assays-market-2632] size is estimated to be valued at USD 5.55 Bn in 2025 and is expected to reach USD 11.82 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032. The global immuno-oncology assays market is experiencing strong growth, driven by the rising incidence of cancer worldwide and the increasing use of targeted therapies for treatment. Immuno-oncology, an emerging area
Bunion Surgery Market to Hit USD 732.9 Million in 2032 amid Rising Prevalence of Bunions | CAGR of 5.9%
Bunion Surgery Market to Hit USD 732.9 Million in 2032 amid Rising Prevalence of …
The Global Bunion Surgery Market [https://www.coherentmarketinsights.com/industry-reports/bunion-surgery-market] is estimated to be valued at USD 490.5 Mn in 2025 and is expected to reach USD 732.9 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032. The market is expected to grow over the forecast period due to the development of advanced bone-repair procedures and the increasing prevalence of bunions worldwide, largely linked to the rise
Pharmacy Automation Market to Hit USD 11.97 Billion by 2032, Fueled by Efforts to Reduce Medication Errors | CAGR of 8.3%
Pharmacy Automation Market to Hit USD 11.97 Billion by 2032, Fueled by Efforts t …
Global Pharmacy Automation Market [https://www.coherentmarketinsights.com/market-insight/pharmacy-automation-market-472] size is projected to reach US$ 11.97 Bn by 2032 from an estimated US$ 6.85 Bn in 2025, exhibiting a CAGR of 8.3%. Pharmacy automation involves the use of mechanical systems that enable pharmacies to dispense medications with minimal human intervention. A variety of automated technologies are employed to ensure medications are dispensed both accurately and efficiently. The most common form of pharmacy automation is
Stem Cells Market to Hit USD 28.24 Billion by 2032 as Regenerative Medicine Demand Surges | CAGR of 9.1%
Stem Cells Market to Hit USD 28.24 Billion by 2032 as Regenerative Medicine Dema …
The global Stem Cells Market [https://www.coherentmarketinsights.com/market-insight/stem-cells-market-4222] is estimated to be valued at USD 15.35 Bn in 2025 and is expected to reach USD 28.24 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032. The stem cells market refers to the rapidly evolving field focused on the use of stem cells for research, regenerative medicine, and therapeutic applications. Stem cells have the unique ability

All 5 Releases


More Releases for RCM

Healthcare RCM Outsourcing Market Report 2024 - RCM Outsourcing Market Trends, S …
"The Business Research Company recently released a comprehensive report on the Global Healthcare RCM Outsourcing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Investigation announced for Investors in R1 RCM Inc. (NASDAQ: RCM) over potentia …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Murray,
Investigation announced for Investors who lost money with shares of R1 RCM Inc. …
An investigation was announced over potential securities laws violations by R1 RCM Inc. in connection with certain financial statements. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of R1 RCM Inc. (NASDAQ: RCM) concerning whether a
Investigation announced for Investors in R1 RCM Inc. (NASDAQ: RCM) over potentia …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its
Investigation announced for Investors in shares of R1 RCM Inc. (NASDAQ: RCM) ove …
An investigation was announced over potential securities laws violations by R1 RCM Inc. and certain of its directors and officers in connection with certain financial statements. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of R1
Investigation announced for Investors in shares of R1 RCM Inc. (NASDAQ: RCM)
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Chicago,